SCHEMBL25755504

SCHEMBL25755504

COc1ccc(NC(=O)c2ccccc2)cc1S(=O)(=O)Nc1ccc(Br)cc1

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.82
KMT2A Q03164 6/20 0.72
ALDH1A1 P00352 5/20 0.72
MEN1 O00255 5/20 0.72
LMNA P02545 4/20 0.72
SMN1; SMN2 Q16637 3/20 0.72
GAA P10253 3/20 0.72
ALOX12 P18054 2/20 0.72
CRHBP P24387 1/20 0.72
CRHR2 Q13324 1/20 0.72
HPGD P15428 2/20 0.65
KDM4E B2RXH2 2/20 0.65
NPC1 O15118 1/20 0.65
HTT P42858 1/20 0.65
TP53 P04637 1/20 0.59
POLB P06746 1/20 0.57
GPR27 Q9NS67 1/20 0.56
TNF P01375 1/20 0.56
NOD2 Q9HC29 1/20 0.56
NOD1 Q9Y239 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27181407 0.90 MAPT (1.00) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL30926791 0.90 MAPT (1.00) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL25755588 0.87 MAPT (0.67) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL25757029 0.85 KMT2A (0.67) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL25755590 0.85 KMT2A (0.67) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL25753999 0.84 KMT2A (0.79) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL25755495 0.83 MAPT (0.67) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL30926466 0.83 MAPT (0.79) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL27180374 0.83 MAPT (0.79) MAPTKMT2AALDH1A1MEN1LMNA
SCHEMBL30926980 0.83 MAPT (0.76) MAPTKMT2AALDH1A1MEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 MAPT 89/4885KMT2A 4864/4885ALDH1A1 2569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.